Citations

Clear

65 citation(s) found for "Karon, M".

Is It Time to Remove Total Calcium from the Basic and Comprehensive Metabolic Panels? Assessing the Effects of American Medical Association–Approved Chemical Test Panels on Laboratory Utilization
Katzman, Brooke M. , Bryant, Sandra C. , Karon, Brad S.

Mayo Clinic

Clinical Chemistry | September 4, 2020 | Volume: 66 | Issue: 11 | Pages: 1444-1449

10.1093/clinchem/hvaa203 | PMID 33141903 Get It

AbstractBackgroundThe necessity of individual tests within the most commonly used disease-oriented test panels has not been well established. We evaluated test-ordering practices for total calcium, both before and after implementation of American Medical Association (AMA)–approved panels (basic metabolic panel [BMP] and comprehensive metabolic panel [CMP]) in our electronic ordering system.MethodsWe performed a retrospective review of all total calcium orders placed during April and June 2018, before and after implementation of the panels. Orders from inpatient, outpatient, and emergency department (ED) care units were totaled, and the percentage of abnormal test results was calculated. We then queried institutional databases to determine the number of unique patients with calcium-related diagnoses and compared the rates from a 5-month period both before and after implementation of the panels.ResultsTotal test volumes and tests per unique patient increased by more than 3-fold after implementation of calcium-containing AMA-approved panels, with the majority of those orders coming from BMPs and CMPs. The rate of low calcium values increased because of the shift toward more inpatient testing; however, the percentage of abnormal results within each patient population (inpatient, outpatient, ED) decreased. The prevalence of hypo- and hypercalcemia-related diagnoses among patients in the 5 months after implementation did not change significantly (1.29% before implementation vs 1.27% after implementation).ConclusionsImplementation of BMPs and CMPs dramatically increased total calcium testing volumes without changing the rate of calcium-related diagnoses. The results suggest that the increase in total calcium orders associated with panel-based testing largely constitutes excess or unnecessary testing.
Implementing High-Sensitivity Cardiac Troponin T in a US Regional Healthcare System
Sandoval, Yader , Askew, J. Wells , Newman, James S. , Clements, Casey M. , Grube, Eric D., Ola, Olatunde , Akula, Ashok , Dworak, Marshall , Wohlrab, Scott, Karon, Brad S. , Jaffe, Allan S. , Grube, Eric D., Jaffe, Allan S.

Mayo Clinic

Circulation | June 8, 2020 | Volume: 141 | Issue: 23 | Pages: 1937-1939

10.1161/circulationaha.119.045480 | PMID 32510995 Get It

Unintended Consequence of High-Dose Vitamin C Therapy for an Oncology Patient: Evaluation of Ascorbic Acid Interference With Three Hospital-Use Glucose Meters
Katzman, Brooke M. , Kelley, Brandon, Deobald, Gayle R., Myhre, Nikki K., Agger, Sean A., Karon, Brad S. , Kelley, Brandon R

Mayo Clinic

Journal of Diabetes Science and Technology | June 7, 2020 | Volume: 15 | Issue: 4 | Pages: 897-900

10.1177/1932296820932186 | PMID 32506941 Get It

The use of high-dose vitamin C in cancer care has offered promising results for some patients. However, the intravenous (IV) doses used for these patients can reach concentrations that interfere with some strip-based glucose meters. We characterized the impact of vitamin C interference, from standard to the very high doses used for some cancer protocols, using three different hospital-use glucose meters. For two of the three devices tested, increasing concentrations of ascorbic acid caused false elevations in the glucose measurements. The third glucose meter did not provide inaccurate results, regardless of the vitamin C concentration present. Rather, above a certain threshold, the device generated error messages and no results could be obtained.
The Effectiveness of Combinations of Antileukemic Agents in Inducing and Maintaining Remission in Children with Acute Leukemia
Frei, Emil, Karon, Myron, Levin, Robert H., Freireich, Emil J., Taylor, Robert , Hananian, Juliet, Selawry, Oleg S., Holland, James F., Hoogstraten, Barth, Wolman, Irving J., Abir, Esshagh, Sawitsky, A, MILLS, STEPHAN D., Burgert, E. Omer, Spurr, Charles L., Patterson, Richard B., Ebaugh, Franklin G., James, G. Watson, Moon, John H., Lee, Stanley Chun-Wei , MILLS, STEPHAN D.

Mayo Clinic

Blood | October 12, 2019 | Volume: 26 | Issue: 5 | Pages: 642-656

10.1182/blood.v26.5.642.642 Get It

Abstract 1. Combinations of effective agents produce at least an additive increase in complete remission rates over that which can be achieved when the agents are used individually. 2. Patients who do not achieve complete remission with initial treatment have a significantly shorter survival. 3. Alternating MTX and 6-MP at 28-day intervals during remission does not prolong the duration of remission over that of combined concurrent 6-MP and MTX. 4. The administration of folic acid antagonists intrathecally at 28-day intervals during antimetabolite maintained remission did not prolong the duration of remission. Meningeal leukemia, however, occurred significantly less frequently in these patients. 5. The duration of combined 6-MP and MTX maintained remission is not greater than that of 6-MP maintained remission. 6. The toxicity of 6-MP and MTX in combination in patients in remission is additive. The above conclusions were drawn from this comparative study of combinations of chemotherapeutic agents in children with acute lymphocytic leukemia.
Real-Time Detection of Analytical Outliers on the Roche Troponin T Generation 5 Assay
Wockenfus, Amy M., Hartung, Katherine J., Kelley, Brandon, Katzman, Brooke M. , Jaffe, Allan S. , Karon, Brad S. , Donato, Leslie J. , Jaffe, Allan S.

Mayo Clinic

American Journal of Clinical Pathology | September 11, 2019 | Volume: 152 | Issue: Supplement_1 | Pages: S83-S83

10.1093/ajcp/aqz116.007 Get It

Abstract Introduction Analytical outliers occur with most troponin assays and can adversely affect patient management. We developed a system to detect analytical outliers for the Roche Troponin T (cTnT) Gen 5 assay using repeat analysis of samples manifesting changing values over 2 to 6 hours. Methods In our ED practice, troponins are collected at baseline, 2 hours, and at times at 6 hours in plasma separator tubes and processed on the Roche Cobas e411 (Indianapolis, IN). When troponin values change by ≥10 ng/L or ≤10 ng/L in the 2- or 6-hour sample compared to baseline, the sample that produced the result is repeated. If initial and repeat values differ by > ±5 ng/L (cTnT <100 ng/L) or ±5% (cTnT ≥100 ng/L), the initial value is deemed to be an analytical outlier. Outliers are confirmed by a third measurement. Results Since March 2018, 19 of 17,154 (0.11%) troponin samples analyzed have been labeled outliers. Outliers were falsely elevated in 14 cases and falsely decreased in 5. Mean (range) of initial cTnT values for outliers was 39 ng/L (18-621 ng/L), with only one initial value >100 ng/L. All changes could affect analysis of change over time. Eleven of 19 outliers were outside gender-specific reference interval on both samples and thus did not cause a change from abnormal to normal. Repeat measurements on 8 of 19 outliers were within the URL, which may have greater clinical consequences. Conclusions Repeat analysis upon observation of changing values allows detection of analytical outliers in real time, prior to reporting results. These outliers are almost always clinically significant in terms of interpretation of changing values and at times change patients from above to below the URL. If we tested more than just changing samples, we might detect still more outliers.
Continuous Improvement of Blood Redraw Rates in the Emergency Department: A 5-Year Journey
Block, Darci R , Griesmann, Laurie D, Rickard, Twyla M, Backus, Linda, Finley, Janet L., Goyal, Deepi G. , Karon, Brad S. , Rickard, Twyla, Finley, Janet, Goyal, Deepi

Mayo Clinic

The Journal of Applied Laboratory Medicine | August 2, 2019 | Volume: 4 | Issue: 2 | Pages: 284-286

10.1373/jalm.2019.029934 | PMID 31639677 Get It

Assessment of Test Performance and Potential for Environmental Contamination Associated with a Point-of-Care Molecular Assay for Group A Streptococcus in an End User Setting
Myhre, Nikki K., Murray, Martha A. , McDonah, Margaret R. , Myers, Jane F., Maxson, Julie, Meek, Alicia M., Espy, Mark J., Furst, Joseph W. , Karon, Brad S. , Binnicker, Matthew J. , Donato, Leslie J. , Maxson, Julie A, Myhre, Nikki K.

Mayo Clinic

Journal of Clinical Microbiology | December 4, 2018 | Volume: 57 | Issue: 2 | Pages: No page available

10.1128/jcm.01629-18 | PMID 30518542 Get It

Although U.S. Food and Drug Administration-approved and CLIA-waived point-of-care (POC) molecular systems are being implemented in routine clinical practice, instrument reliability, test performance in the hands of end users, and the potential for environmental contamination resulting from use of POC molecular systems have not been extensively evaluated.
Working With Your Practice to Ensure Appropriate Point-of-Care Usage
Karon, Brad S. , Donato, Leslie J.

Mayo Clinic

The Journal of Applied Laboratory Medicine | July 23, 2018 | Volume: 1 | Issue: 5 | Pages: 603-604

10.1373/jalm.2016.021774 | PMID 33379804 Get It

Accuracy of Capillary and Arterial Whole Blood Glucose Measurements Using a Glucose Meter in Patients under General Anesthesia in the Operating Room
Karon, Brad S. , Larsen, Chelsie M., Siebenaler, Lindsay K., Wells, Amy E., Wood‐Wentz, Christina M. , Shirk-Marienau, Mary E., Curry, Timothy B. , Donato, Leslie J.

Mayo Clinic

Anesthesiology | May 27, 2017 | Volume: 127 | Issue: 3 | Pages: 466-474

10.1097/aln.0000000000001708 | PMID 28557817 Get It

Abstract Background The aim of this study was to evaluate the use of a glucose meter with surgical patients under general anesthesia in the operating room. Methods Glucose measurements were performed intraoperatively on 368 paired capillary and arterial whole blood samples using a Nova StatStrip (Nova Biomedical, USA) glucose meter and compared with 368 reference arterial whole blood glucose measurements by blood gas analyzer in 196 patients. Primary outcomes were median bias (meter minus reference), percentage of glucose meter samples meeting accuracy criteria for subcutaneous insulin dosing as defined by Parkes error grid analysis for type 1 diabetes mellitus, and accuracy criteria for intravenous insulin infusion as defined by Clinical and Laboratory Standards Institute guidelines. Time under anesthesia, patient position, diabetes status, and other variables were studied to determine whether any affected glucose meter bias. Results Median bias (interquartile range) was −4 mg/dl (−9 to 0 mg/dl), which did not differ from median arterial meter bias of −5 mg/dl (−9 to −1 mg/dl; P = 0.32). All of the capillary and arterial glucose meter values met acceptability criteria for subcutaneous insulin dosing, whereas only 89% (327 of 368) of capillary and 93% (344 of 368) arterial glucose meter values met accuracy criteria for intravenous insulin infusion. Time, patient position, and diabetes status were not associated with meter bias. Conclusions Capillary and arterial blood glucose measured using the glucose meter are acceptable for intraoperative subcutaneous insulin dosing. Whole blood glucose on the meter did not meet accuracy guidelines established specifically for more intensive ( e.g. , intravenous insulin) glycemic control in the acute care environment.
Advances Afoot in Microbiology
Patel, Robin , Karon, Brad S. , Patel, Robin

Mayo Clinic

Journal of Clinical Microbiology | May 25, 2017 | Volume: 55 | Issue: 7 | Pages: 1984-1988

10.1128/jcm.00664-17 | PMID 28539341 Get It

ABSTRACT In 2016, the American Academy of Microbiology convened a colloquium to examine point-of-care (POC) microbiology testing and to evaluate its effects on clinical microbiology. Colloquium participants included representatives from clinical microbiology laboratories, industry, and the government, who together made recommendations regarding the implementation, oversight, and evaluation of POC microbiology testing. The colloquium report is timely and well written (V. Dolen et al., Changing Diagnostic Paradigms for Microbiology , 2017, https://www.asm.org/index.php/colloquium-reports/item/6421-changing-diagnostic-paradigms-for-microbiology?utm_source=Commentary&utm_medium=referral&utm_campaign=diagnostics ). Emerging POC microbiology tests, especially nucleic acid amplification tests, have the potential to advance medical care.